Yanchao Ma

Yanchao Ma

Auto-generated profile, based on publicly available information

Yanchao Ma

Affiliation Department of Immunology, Binzhou Medical University, Yantai, Shandong, China

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2015 in Gene
Verified
Journal Article
Closed access
MLMing Li
Ming Li
YMYanchao Ma
Yanchao Ma
PHPei Huang
Pei Huang
ADAonan Du
Aonan Du
XYXiaodong Yang
Xiaodong Yang
JCJianping Cao
Jianping Cao


24 March 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
XLXiuxin Liu
Xiuxin Liu
YHYuhui Han
Yuhui Han
RKRuixue Kuang
Ruixue Kuang
WSWenjiong Sheng
Wenjiong Sheng
YZYan Zhang
Yan Zhang
YMYanchao Ma
Yanchao Ma
DNA damage-induced by radiotherapy is a critical factor in promoting the death of colorectal cancer cells (CRC). Although high mobility group box 1 (HMGB1) reportedly plays a vital role in tumor radioresistance by modulating DNA damage repair, the precise mechanisms remain unclear. In this study, HMGB1 knockdown markedly enhanced cell apoptosis after radiation. HMGB1 downregulation significantly inhibited DNA damage repair and reactive oxygen species (ROS)-mediated redox homeostasis after irradiation in CRC cells. Mechanistically, HMGB1 interacts with KU70 via its region spanning residues 95–163. This interaction subsequently activates the non-homologous end joining (NHEJ) pathway to facilitate DNA damage repair, ultimately leading to reduced radiation-induced cell apoptosis. KU70 silencing showed the same effect as HMGB1 depletion mediated cell apoptosis and DNA damage response both in vitro and in vivo . Additionally, HMGB1 and KU70 were overexpressed in CRC tissues. Analysis of the GEPIA database indicated that elevated levels of both genes showed a trend toward association with poor patient prognosis, although this did not reach statistical significance. The current study revealed that HMGB1 may promote DNA damage repair through KU70 and its mediated NHEJ pathway to affect apoptosis in CRC cells after irradiation. Thus, targeting the HMGB1/KU70/NHEJ axis may be a potential therapeutic target to promote the response of CRC to radiotherapy and in-depth study of the specific mechanism of this axis in CRC radioresistance will help to the develop more effective treatment strategies.

1 December 2025 in Advances in Medical Education and Practice
Verified
Journal Article
Open access
PDF file
YMYanchao Ma
Yanchao Ma
BWBin Wang
Bin Wang
YJYuzhu Jiang
Yuzhu Jiang
QCQizhi Cao
Qizhi Cao
THTao Hu
Tao Hu
XLXiying Luan
Xiying Luan
Objective: Due the concept of medical immunology is abstract and difficult to align with the “holism and balance of Yin and Yang” in traditional Chinese medicine (TCM), students feel intimidated and have weak identification with it. This study has constructed a “holism-based blended teaching model” and verified its promoting effect on knowledge, grades, and professional identification. Methods: A cross-sectional study design was adopted. A blended teaching method based on the Zhihuishu platform was used to survey 201 students majoring in TCM. The data were collected through the Wenjuanxing scale and analyzed using descriptive statistical methods. Additionally, an independent t-test was used to compare the academic performance of the blended learning group (Grades 2019– 2022) and the traditional learning group (Grades 2018). Results: More than 85% of the students were able to integrate knowledge such as T cell dual signals and complement modulation within the framework of balance between Yin and Yang. In the experimental group, 16.29% scored above 90 points, 41.63% scored between 80 and 89 points, which were significantly better than those of the control group (3.57% and 20.41%). Moreover, 92.04% approved of the model, and 76.61% believed it enhanced professional qualities. 76.6% deepened their understanding of the overall perspective, and 82.4% were willing to adopt a combination of traditional and modern medicine thinking. Conclusion: The research results indicate that this blended teaching method helps students better integrate the holism of TCM to understand immunology knowledge. Moreover, the students’ self-study abilities and academic performance have also significantly improved. These findings enable the basic knowledge of immunology to better serve the training of professionals in TCM.

29 July 2026 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
RQRong Qi
Rong Qi
HZHengchao Zhang
Hengchao Zhang
YWYunhua Wu
Yunhua Wu
YMYanchao Ma
Yanchao Ma
XLXiying Luan
Xiying Luan
Purpose: To investigate the expression profile of IL‐6 in patients with acute promyelocytic leukemia (APL) and its role in modulating the ability of hPMSCs to regulate the differentiation of NB4 cells. Methods: Peripheral blood samples were obtained from newly diagnosed APL patients and healthy controls. IL‐6 levels were measured using flow cytometry‐based (FCM) multiplex immunoassays. A co‐culture system of hPMSCs and NB4 cells was established. The effects of hPMSCs on ATRA‐induced differentiation, proliferation, and phagocytic activity of NB4 cells were evaluated by Wright–Giemsa staining, FCM, CCK‐8 assays, and phagocytosis assays. Western blot analysis was performed to investigate the signaling mechanisms by which IL‐6 regulates CD73 expression in hPMSCs. To determine whether the regulatory effects of hPMSCs are mediated by CD73, interventions using a CD73 inhibitor and CD73‐knockdown hPMSCs were conducted. Results: IL‐6 levels were significantly elevated in the peripheral blood of APL patients and showed a positive correlation with both risk stratification and the severity of retinoic acid syndrome (RAS). hPMSCs enhanced ATRA‐induced differentiation of NB4 cells while suppressing their proliferation and phagocytic function. Moreover, inhibition or knockdown of CD73 markedly attenuated the pro‐differentiation effect of hPMSCs on NB4 cells. NB4 cells exhibited high surface expression of adenosine receptors. IL‐6 was found to upregulate CD73 expression in hPMSCs through activation of the PI3K/AKT signaling pathway. Conclusions: IL‐6 enhances the pro‐differentiation capacity of hPMSCs toward NB4 cells by upregulating CD73 expression, offering a potential new strategy for the clinical treatment of APL.